Lung transplant is a possible option for those who have severe lung problems that are caused by cystic fibrosis. This involves removal of the diseased lungs and replacing them with healthy lungs from a recently deceased donor.
Living-donor lobar lung transplant is in certain cases performed while a person is waiting for a full lung transplant. In this procedure, the lower lobe of one lung in each of two living donors is transplanted into the person who has the diesesased lung. Because this complicated transplant involves two living donors, it is performed less often than other kinds of lung transplants.
The patient is put on a ventilator after the transplant surgery which takes over the breathing process. The patient will be on ventilator support for a minimum of 2 days post operative. Typical hospital stay is for 2 to 3 weeks after the transplant.
Those who have a Lung damage caused by cystic fibrosis may get a lung transplant. The risks are greater than the benefits, so people who have mild or moderate disease do not usually get a transplant. Certain test like Lung Function Tests, blood gas tests (arterial) and exercise capacity.
A detailed comprehensive evaluation to find out how severe the lung disease is, whether you have any other diseases and whether you are able to follow a complex pre-transplant and follow-up regimen is required before one qualifies for lung transplant.
The expected number of days lived without a transplant
The expected number of days lived during the first year after getting a transplant
The post-transplant survival measure minus the expected number of days lived without a transplant.
On an average about 70 out of 100 people who receive a lung transplant survive at least 1 year after the procedure. And about 48 out of 100 survive at least 5 years.
People with cystic fibrosis have the same survival rate after a lung transplant as people who have lung transplants for other health problems.
Lung transplant is used only for people who have very severe cystic fibrosis. For people who have mild or moderate cystic fibrosis, the risks of the procedure are greater than the benefits.